Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medication Augmentation vs PST in Older Adults with Depression
NCT01942187Phase 4Withdrawn
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole, bupropion in major depressive disorder (MDD), persistent depressive disorder (PDD), depressive disorder not otherwise specified (DD-NOS), sponsored by New York State Psychiatric Institute. Planned start Aug 2013; status: withdrawn.
02
Drugs
aripiprazolebupropion
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)depressive disorder not otherwise specified (DD-NOS)
Beyond the preview
Go deeper on NCT01942187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01942187.